FTI Consulting appoints new head of U.S. Antitrust practice

Published 10/03/2025, 12:38
FTI Consulting appoints new head of U.S. Antitrust practice

WASHINGTON - FTI Consulting, Inc. (NYSE: FCN), a global consulting firm with a market capitalization of approximately $6 billion and annual revenues of $3.69 billion, announced today that Dr. Mary T. Coleman has been appointed as the Head of the U.S. Antitrust practice at its Compass Lexecon subsidiary. Dr. Coleman, who is an Executive Vice President based in Boston, will now oversee the company’s antitrust activities across the United States and coordinate with international teams. According to InvestingPro, the company maintains a strong financial position with more cash than debt on its balance sheet.

Dr. Coleman is known for her expertise in the competitive analysis of mergers, acquisitions, joint ventures, and antitrust litigation, including issues related to liability and class-action certification. Her experience includes presenting before U.S. and foreign antitrust authorities, submitting expert testimony in federal court, and testifying in state court.

Previously, Dr. Coleman served as the Deputy Director for Antitrust in the Bureau of Economics at the Federal Trade Commission from 2001 to 2004, where she played a key role in antitrust investigations and promoted cooperation between economic and legal staff, as well as between the FTC and foreign jurisdictions. This appointment comes at a crucial time for FTI Consulting, as the company’s stock has experienced a 22.6% decline over the past six months and currently trades near its 52-week low.

In her new role, Dr. Coleman aims to lead her team in providing expert economic analysis on complex competition issues and assisting clients with the evolving regulatory landscape. Her appointment reflects Compass Lexecon’s commitment to maintaining its position as a leading economic consulting firm globally.

FTI Consulting, a global expert firm, assists organizations during crisis and transformation and reported revenues of $3.69 billion for the fiscal year 2024. The company employs over 8,300 staff in 34 countries and territories. InvestingPro analysis indicates the company maintains a "GOOD" overall financial health score, with strong cash flows and robust liquidity ratios. This appointment is based on a press release statement from FTI Consulting, Inc. For detailed insights into FCN’s valuation and growth prospects, including 12 additional ProTips, check out the comprehensive Pro Research Report available on InvestingPro.

In other recent news, FTI Consulting reported its financial results for the fourth quarter and full year ending December 31, 2024. The company announced a fourth-quarter earnings per share (EPS) of $1.56, which fell short of the consensus estimate of $1.73, and revenue of $894.9 million, below the expected $932.18 million. For the full year, FTI Consulting achieved a 6% increase in revenue, reaching $3.699 billion, but faced challenges in the second half of the year. The company has provided guidance for 2025, expecting full-year EPS to range between $7.80 and $8.60, and revenue between $3.66 billion and $3.81 billion, both below analyst expectations.

In response to these results, Truist Securities adjusted its price target for FTI Consulting stock to $225 from $275 but maintained a Buy rating, indicating confidence in the company’s potential for recovery. The firm cited challenges within FTI Consulting’s Economic Consulting segment and slower capital markets activity as contributing factors to the lowered outlook. Additionally, FTI Consulting announced a special charge of approximately $17 million in the first quarter of 2025 related to staffing alignment, following an $8.2 million charge in the fourth quarter of 2024.

FTI Consulting also strengthened its Forensic and Litigation Consulting segment by appointing three senior managing directors in Asia and Latin America. These appointments are expected to enhance the firm’s ability to manage risks and investigations in high-risk markets. The company reported revenues of $3.69 billion for the fiscal year 2024, reinforcing its position in the forensic and litigation consulting market.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.